About PRECOS
PRECOS is a company based in United Kingdom founded in 2010 was acquired by Crown Bioscience in July 2013. The company has 8 employees as of May 31, 2021. PRECOS operates in a competitive market with competitors including Orakl Oncology, Oncodesign, Orange Grove Bio LLC, Lytica Therapeutics and LumaBridge, among others.
- Headquarter United Kingdom
- Employees 8 as on 31 May, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Proweb (Uk) Limited
- Date of Incorporation 21 Feb, 1996
- Jurisdiction NOTTINGHAM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
8
as on May 31, 2021
-
Acquired by
Crown Bioscience
(Jul 30, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of PRECOS
Detailed funding history for PRECOS
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in PRECOS
PRECOS has secured backing from 1 investor. Prominent investors backing the company include Crown Bioscience.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cancer and CVMD drugs are developed using PDX models.
|
Locked | Locked | Locked |
Investor details for PRECOS
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PRECOS
Investment portfolio details for PRECOS
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PRECOS
Detailed financials for PRECOS
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Precos Comparisons
Peer comparison for PRECOS
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PRECOS
PRECOS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orakl Oncology, Oncodesign, Orange Grove Bio LLC, Lytica Therapeutics and LumaBridge, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Orakl Oncology is a precision oncology start-up that enables the emergence of rare oncology by connecting patient tumors to the world's 3rd best cancer center.
|
|
| Locked | Locked | Locked |
Preclinical assessment services for anti-cancer therapies are provided.
|
|
| Locked | Locked | Locked |
Provider of preclinical development services
|
|
| Locked | Locked | Locked |
Therapeutic drugs are developed for medical applications.
|
|
| Locked | Locked | Locked |
Provider of oncology clinical research, regulatory affairs, and data management services
|
|
| Locked | Locked | Locked |
Developer of immune assays for the diagnosis of cancer
|
Detailed competitors of PRECOS
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Precos
Complete news archive for PRECOS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PRECOS
PRECOS was founded in 2010.
PRECOS is headquartered in United Kingdom.
As of May 31, 2021, the latest employee count at PRECOS is 8.
PRECOS was founded in 2010 in the United Kingdom, focusing on the oncology drug development sector. Preclinical services, including patient-derived xenograft, orthotopic, and metastatic modeling along with imaging, were delivered. Models that mirrored cancer progression stagessuch as pre-cancerous lesions, primary tumors, and metastasiswere employed to support research. Acquisition by Crown Bioscience occurred in 2013.
PRECOS's top competitors include Oncodesign, Orakl Oncology and Lytica Therapeutics.
PRECOS has 1 investor. Key investors include Crown Bioscience.